Scientific Breakthrough to Save Horses from Being Abused for Diptheria 'Antitoxins'
Alternatives to Animal Testing, Experimentation and Dissection - An Animal Rights Article from All-Creatures.org

FROM PETA International Science Consortium Ltd
February 2020

A project that’s taking the first steps towards ending the use of horses in India and elsewhere to treat diphtheria has succeeded. And the Science Consortium is already working on its next target – replacing the use of horses to make a treatment for black widow spider bites – and won‘t stop until animals are no longer used to make these drugs.

Funded by the PETA International Science Consortium Ltd and carried out at the Institute of Biochemistry, Biotechnology, and Bioinformatics at the Technische Universität Braunschweig in Germany, the project created fully human-derived antibodies capable of blocking the poisonous toxin that causes diphtheria. The results of the research were just published in Scientific Reports (a research journal published by Nature Publishing Group) and covered on 17 January in an article in Science.

Diphtheria is a potentially deadly infectious disease causing severe respiratory distress and damage to vital organs. For more than 100 years, the main method of producing the antitoxin to treat it has been to inject horses repeatedly with the diphtheria toxin and then drain huge amounts of their blood in order to collect the antibodies that their immune systems produce to fight the disease. Not only does this animal-derived antitoxin have the potential to cause serious allergic reactions in patients who receive it, global health authorities also report having difficulty acquiring sufficient stockpiles of it to respond quickly to diphtheria outbreaks.

Inspections of facilities where horses are used to produce animal-derived antitoxins have found widespread neglect of animal welfare, with horses confined to filthy, severely crowded enclosures and suffering from anaemia, diseased hooves, eye abnormalities, infections, parasites, and malnutrition.

Rather than using horses, the researchers involved in this project used human blood cells to generate human-derived antibodies that block the diphtheria toxin. The Science Consortium is now working with its research partners to ensure that the non-animal antitoxin is developed into a medicine that will be used to treat this menacing disease more reliably and safely, without causing a single horse to suffer.

The Science Consortium is already working on its next target – replacing the use of horses to make a treatment for black widow spider bites – and won‘t stop until animals are no longer used to make these drugs.

---

Return to Alternatives to Animal Testing, Experimentation and Dissection